摘要
丙氨酸的功能缺陷:乙醛酸氨基转移酶(AGT)在人类肝细胞导致一种罕见的隐性遗传疾病,称为原发性高草酸尿症I型(PH1)。原发性高草酸尿症I型的特点是在肾脏和泌尿道逐步积累和沉积草酸钙结石,导致危及生命的和潜在的致命条件。在过去的几十年中,疾病的分子发病机制的实质性进展的阐述已取得进展。导致了一些方面的理解,许多突变导致乙醛酸氨基转移酶缺乏通过影响导致降低表达水平的蛋白折叠途径,增加的聚集倾向,和/或异常的线粒体定位。因此,可以认为是一个错误折叠疾病原发性高草酸尿症I型,旨在抵消变异的构象缺陷可能治疗方法。在这篇综述中,我们总结了在发展的识别分子救援乙醛酸氨基转移酶折叠运输新策略进展,无论是作为药物分子伴侣或防止蛋白质靶向错误。
关键词: 原发性高草酸尿症I型,丙氨酸,乙醛酸氨基转移酶,错误折叠疾病,5’-磷酸吡哆醛,致病变种,药物分子伴侣。
图形摘要
Current Drug Targets
Title:Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I
Volume: 17 Issue: 13
Author(s): Elisa Oppici, Riccardo Montioli, Mirco Dindo, Barbara Cellini
Affiliation:
关键词: 原发性高草酸尿症I型,丙氨酸,乙醛酸氨基转移酶,错误折叠疾病,5’-磷酸吡哆醛,致病变种,药物分子伴侣。
摘要: The functional deficit of alanine:glyoxylate aminotransferase (AGT) in human hepatocytes leads to a rare recessive disorder named primary hyperoxaluria type I (PH1). PH1 is characterized by the progressive accumulation and deposition of calcium oxalate stones in the kidneys and urinary tract, leading to a life-threatening and potentially fatal condition. In the last decades, substantial progress in the clarification of the molecular pathogenesis of the disease have been made. They resulted in the understanding that many mutations cause AGT deficiency by affecting the folding pathway of the protein leading to a reduced expression level, an increased aggregation propensity, and/or an aberrant mitochondrial localization. Thus, PH1 can be considered a misfolding disease and possibly treated by approaches aimed at counteracting the conformational defects of the variants. In this review, we summarize recent advances in the development of new strategies to identify molecules able to rescue AGT folding and trafficking either by acting as pharmacological chaperones or by preventing the mistargeting of the protein.
Export Options
About this article
Cite this article as:
Elisa Oppici, Riccardo Montioli, Mirco Dindo, Barbara Cellini , Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I, Current Drug Targets 2016; 17 (13) . https://dx.doi.org/10.2174/1389450117666160302095254
DOI https://dx.doi.org/10.2174/1389450117666160302095254 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Complex II from a Structural Perspective
Current Protein & Peptide Science Potentiation of Antidepressant-Like Activity with Lithium: Mechanism Involved
Current Drug Targets Ghrelin: New Insight to Mechanisms and Treatment of Postoperative Gastric Ileus
Current Pharmaceutical Design Fast Disintegrating Film Approach for the Oral Delivery of Zolmitriptan: Formulation, <i>In Vitro</i> and <i>In Vivo</i> Evaluation
Drug Delivery Letters Safety and Complications Reporting Update on the Re-Implantation of Culture-Expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique
Current Stem Cell Research & Therapy The Effects of Aerobic Exercise on Cognitive Function of Alzheimer's Disease Patients
CNS & Neurological Disorders - Drug Targets Can Increased Food Intake Improve Psychosis? A Brief Review and Hypothesis
Current Molecular Pharmacology From Structure to Function: Methods and Applications
Current Protein & Peptide Science Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Current Genomics Clearance of Beta-Amyloid in the Brain
Current Medicinal Chemistry Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis
Current Alzheimer Research Solution NMR Studies of Aβ Monomer Dynamics
Protein & Peptide Letters Understanding the Molecular Mechanisms of Rifaximin in the Treatment of Gastrointestinal Disorders – A Focus on the Modulation of Host Tissue Function
Mini-Reviews in Medicinal Chemistry Cellular Mechanisms of Bypass Vein Graft Arterialization and Approaches to Attenuate Graft Remodeling
Vascular Disease Prevention (Discontinued) New Pharmacological Perspectives and Therapeutic Potential of PPAR-γ Agonists
Current Pharmaceutical Design High Throughput Crystallography of TB Drug Targets
Infectious Disorders - Drug Targets A Dual Mode Pulsed Electro-Magnetic Cell Stimulator Produces Acceleration of Myogenic Differentiation
Recent Patents on Biotechnology The Therapeutic Potential of Purinergic Receptors in Alzheimer’s Disease and Promising Therapeutic Modulators
Mini-Reviews in Medicinal Chemistry Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology